» Articles » PMID: 38147174

The Japanese Breast Cancer Society Clinical Practice Guidelines for Epidemiology and Prevention of Breast Cancer, 2022 Edition

Abstract

The Japanese Breast Cancer Society Clinical Practice Guidelines for Epidemiology and Prevention of Breast Cancer, 2022 Edition.

Citing Articles

A Scoping Review of Primary Breast Cancer Risk Reduction Strategies in East and Southeast Asia.

Alpeza F, Loo C, Zhuang Q, Hartman M, Goh S, Li J Cancers (Basel). 2025; 17(2).

PMID: 39857949 PMC: 11763974. DOI: 10.3390/cancers17020168.


The role of multiparametric MRI in predicting lymphovascular invasion in breast cancer patients.

Wang J, Jing S, Yang Z, Tan W, Liu Y Future Oncol. 2024; 20(35):2747-2756.

PMID: 39268927 PMC: 11572066. DOI: 10.1080/14796694.2024.2396273.


Percutaneous ultrasound-guided cryoablation for early-stage primary breast cancer: a follow-up study in Japan.

Kawamoto H, Tsugawa K, Furuya Y, Sakamaki K, Kakimoto S, Kitajima M Breast Cancer. 2024; 31(4):695-704.

PMID: 38678120 PMC: 11194206. DOI: 10.1007/s12282-024-01584-4.


The Japanese Breast Cancer Society Clinical Practice Guidelines for Breast Cancer, 2022 Edition: changes from the 2018 edition and general statements on breast cancer treatment.

Yamamoto Y, Yamauchi C, Toyama T, Nagai S, Sakai T, Kutomi G Breast Cancer. 2024; 31(3):340-346.

PMID: 38570435 PMC: 11045566. DOI: 10.1007/s12282-024-01566-6.


Searching for the "Holy Grail" of breast cancer recurrence risk: a narrative review of the hunt for a better biomarker and the promise of circulating tumor DNA (ctDNA).

Gao L, Medford A, Spring L, Bar Y, Hu B, Jimenez R Breast Cancer Res Treat. 2024; 205(2):211-226.

PMID: 38355821 DOI: 10.1007/s10549-024-07253-6.

References
1.
Taira N, Arai M, Ikeda M, Iwasaki M, Okamura H, Takamatsu K . The Japanese Breast Cancer Society clinical practice guideline for epidemiology and prevention of breast cancer. Breast Cancer. 2014; 22(1):16-27. DOI: 10.1007/s12282-014-0555-x. View

2.
Momozawa Y, Iwasaki Y, Parsons M, Kamatani Y, Takahashi A, Tamura C . Germline pathogenic variants of 11 breast cancer genes in 7,051 Japanese patients and 11,241 controls. Nat Commun. 2018; 9(1):4083. PMC: 6172276. DOI: 10.1038/s41467-018-06581-8. View

3.
. Cancer incidence in five continents. IARC Sci Publ (1971). 1976; (15):1-583. View

4.
Iwata H, Saji S, Ikeda M, Inokuchi M, Uematsu T, Toyama T . The Japanese Breast Cancer Society Clinical Practice Guidelines, 2018 edition: the tool for shared decision making between doctor and patient. Breast Cancer. 2019; 27(1):1-3. PMC: 8134297. DOI: 10.1007/s12282-019-01021-x. View

5.
Takeuchi T, Kitamura Y, Sobue T, Utada M, Ozasa K, Sugawara Y . Impact of reproductive factors on breast cancer incidence: Pooled analysis of nine cohort studies in Japan. Cancer Med. 2021; 10(6):2153-2163. PMC: 7957169. DOI: 10.1002/cam4.3752. View